tumor
-
Health
Drug Approved to Treat Tenosynovial Giant Cell Tumor
MONDAY, Aug. 5, 2019 (HealthDay News) — Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant…
Read More » -
Health
Neoadjuvant Radiotherapy Beneficial in Resectable Liver Cancer With Portal Vein Tumor Thrombus
NEW YORK (Reuters Health) – Neoadjuvant three-dimensional conformal radiotherapy (RT) followed by hepatectomy boosts outcomes over those with hepatectomy alone…
Read More » -
Health
FDA Approves First Drug for Tenosynovial Giant Cell Tumor
The US Food and Drug Administration (FDA) today approved the novel oral therapy pexidartinib (Turalio, Daiichi Sankyo) for the treatment…
Read More » -
Health
Bevacizumab Benefit in Large-Volume Ovarian Cancer
Hopes that extended antiangiogenesis exposure with bevacizumab (multiple brands) might stave off tumor growth more effectively than a standard chemotherapy…
Read More » -
Health
EU OK for First ‘Histology-Independent’ Cancer Drug
The first so-called histology-independent cancer treatment has been recommended for approval in the European Union. The product is larotrectinib (Vitrakvi,…
Read More » -
Health
Even Before Cancer Is Diagnosed, Some Clones Have Spread
Metastases are generally thought of as a later event that occurs some time after the primary cancer develops, but new…
Read More » -
Health
Exosomal Induction of Tumor Innervation
Abstract The naïve view of tumors as isolated islands of rogue cells has given way to a deeper understanding of…
Read More » -
Health
Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies
The importance of preexisting versus acquired drug resistance in patients with cancer treated with small-molecule tyrosine kinase inhibitors (TKI) remains…
Read More » -
Health
Rise in GI Cancers in Younger Adults: Unraveling the Why
BARCELONA — The increase in younger-onset gastrointestinal cancer is creating an ever-growing population of patients who have substantial unmet needs,…
Read More » -
Health
High Prevalence of PD-L1 Expression in Non-Small-cell Lung Cancer
NEW YORK (Reuters Health) – The expression of programmed death ligand 1 (PD-L1) is common in locally advanced or metastatic…
Read More »